drugset / Trial / NCT02389868

Effects of Lovastatin on Human Platelet Proteome

NCT02389868

Phase 2 Completed 15 enrolled University of Sherbrooke
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the effects induced by the cholesterol-reducing drug Lovastatin on the platelet proteome of healthy volunteers. Our results may allow to recognize the cell signalling modifications induced by Lovastatin. Furthermore, the current study aims to characterize the biological and inter-individual variation of platelet's proteome as measured by liquid chromatography-tandem mass spectrometry. Lastly, the exploration of changes induced by Lovastatin on the platelet's proteome may allow the discovery of modifications relative to the effects of statins on hemostasis and the lipid profile.

Timeline

Start
2015-02
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovastatin Small molecule

Indications

No indication recorded.